Wang Lai
Officer at ONC
- Sold, on record
- $10M
- Dollars the filings state
- Form 4 sales
- 23
- Latest Jun 23, 2026
- Form 144 notices
- 18
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ONCBeOne Medicines Ltd.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ONCNoticeJun 8, 2026 2026
Filed to sell 1,367 shares ($368k)
Wang Lai, Officer
No 10b5-1 plan0.7x usual sizeFiling
- 2 Form 4 sale ONCUnusualJun 8, 2026 same day
Sold 1,367 shares at $269.38 ($368k)
Wang Lai, President, Global Head of R&D
No 10b5-1 planSold 100% of holdings ($368k position)0 shares left0.7x usual sizeFollows a Form 144Filing
- 3 Form 144 notice ONCNoticeJun 11, 2026 +3 days
Filed to sell 756 shares ($198k)
Wang Lai, Officer
No 10b5-1 plan0.5x usual sizeFiling
- 4 Form 4 sale ONCUnusualJun 11, 2026 same day
Sold 756 shares at $261.00 ($197k)
Wang Lai, President, Global Head of R&D
No 10b5-1 planSold 100% of holdings ($197k position)0 shares left0.5x usual sizeFollows a Form 144Filing
- 5 Form 144 notice ONCNoticeJun 16, 2026 +5 days
Filed to sell 1,169 shares ($310k)
Wang Lai, Officer
No 10b5-1 plan0.8x usual sizeFiling
- 6 Form 4 sale ONCUnusualJun 16, 2026 same day
Sold 1,169 shares at $265.39 ($310k)
Wang Lai, President, Global Head of R&D
No 10b5-1 planSold 100% of holdings ($310k position)0 shares left0.8x usual sizeFollows a Form 144Filing
- 7 Form 144 notice ONCNoticeJun 23, 2026 +7 days
Filed to sell 1,068 shares ($296k)
Wang Lai, Officer
No 10b5-1 plan0.8x usual sizeFiling
- 8 Form 4 sale ONCUnusualJun 23, 2026 same day
Sold 1,068 shares at $276.74 ($296k)
Wang Lai, President, Global Head of R&D
No 10b5-1 planSold 100% of holdings ($296k position)0 shares left0.8x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (41)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Jun 25, 2026 | ONC | President, Global Head of R&D | Form 4 sale | 1,068 | $296k | 100.0% | Unusual | SEC |
| Jun 23, 2026 | Jun 23, 2026 | ONC | Officer | Form 144 notice | 1,068 | $296k | Notice | SEC | |
| Jun 16, 2026 | Jun 18, 2026 | ONC | President, Global Head of R&D | Form 4 sale | 1,169 | $310k | 100.0% | Unusual | SEC |
| Jun 16, 2026 | Jun 16, 2026 | ONC | Officer | Form 144 notice | 1,169 | $310k | Notice | SEC | |
| Jun 11, 2026 | Jun 15, 2026 | ONC | President, Global Head of R&D | Form 4 sale | 756 | $197k | 100.0% | Unusual | SEC |
| Jun 11, 2026 | Jun 11, 2026 | ONC | Officer | Form 144 notice | 756 | $198k | Notice | SEC | |
| Jun 8, 2026 | Jun 10, 2026 | ONC | President, Global Head of R&D | Form 4 sale | 1,367 | $368k | 100.0% | Unusual | SEC |
| Jun 8, 2026 | Jun 8, 2026 | ONC | Officer | Form 144 notice | 1,367 | $368k | Notice | SEC | |
| Sep 9, 2025 | Sep 11, 2025 | ONC | Global Head of R&D | Form 4 sale | 5,000 | $1.8M | 100.0% | Unusual | SEC |
| Sep 9, 2025 | Sep 9, 2025 | ONC | Officer | Form 144 notice | 5,000 | $1.7M | Notice | SEC | |
| Jul 30, 2025 | Jul 31, 2025 | ONC | Global Head of R&D | Form 4 sale | 4,300 | $1.3M | 100.0% | Routine | SEC |
| Jul 18, 2025 | Jul 22, 2025 | ONC | Global Head of R&D | Form 4 sale | 700 | $210k | 100.0% | Routine | SEC |
| Jul 18, 2025 | Jul 18, 2025 | ONC | Officer | Form 144 notice | 5,000 | $1.5M | Notice | SEC | |
| Jun 23, 2025 | Jun 25, 2025 | ONC | Global Head of R&D | Form 4 sale | 1,028 | $267k | 100.0% | Unusual | SEC |
| Jun 23, 2025 | Jun 23, 2025 | ONC | Officer | Form 144 notice | 1,028 | $267k | Notice | SEC | |
| Jun 17, 2025 | Jun 18, 2025 | ONC | Global Head of R&D | Form 4 sale | 1,647 | $432k | 100.0% | Unusual | SEC |
| Jun 17, 2025 | Jun 17, 2025 | ONC | Officer | Form 144 notice | 470 | $118k | Notice | SEC | |
| Jun 16, 2025 | Jun 16, 2025 | ONC | Officer | Form 144 notice | 1,177 | $314k | Notice | SEC | |
| Jun 6, 2025 | Jun 10, 2025 | ONC | Global Head of R&D | Form 4 sale | 1,402 | $354k | 100.0% | Unusual | SEC |
| Jun 6, 2025 | Jun 6, 2025 | ONC | Officer | Form 144 notice | 1,402 | $354k | Notice | SEC | |
| Feb 21, 2025 | Feb 25, 2025 | ONC | Global Head of R&D | Form 4 sale | 5,000 | $1.3M | 100.0% | Unusual | SEC |
| Feb 21, 2025 | Feb 21, 2025 | ONC | Officer | Form 144 notice | 5,000 | $1.2M | Notice | SEC | |
| Sep 27, 2024 | Oct 1, 2024 | ONC | Global Head of R&D | Form 4 sale | 5,000 | $1.1M | 100.0% | Unusual | SEC |
| Sep 27, 2024 | Sep 27, 2024 | ONC | Officer | Form 144 notice | 5,000 | $1.1M | Notice | SEC | |
| Jun 24, 2024 | Jun 26, 2024 | ONC | Global Head of R&D | Form 4 sale | 1,064 | $170k | 100.0% | Unusual | SEC |
| Jun 24, 2024 | Jun 24, 2024 | ONC | Officer | Form 144 notice | 1,064 | $170k | Notice | SEC | |
| Jun 18, 2024 | Jun 20, 2024 | ONC | Global Head of R&D | Form 4 sale | 2,341 | $368k | 100.0% | Unusual | SEC |
| Jun 18, 2024 | Jun 18, 2024 | ONC | Officer | Form 144 notice | 841 | $129k | Notice | SEC | |
| Jun 17, 2024 | Jun 17, 2024 | ONC | Officer | Form 144 notice | 1,500 | $239k | Notice | SEC | |
| Jun 26, 2023 | Jun 27, 2023 | ONC | Global Head of R&D | Form 4 sale | 1,108 | $202k | 100.0% | Unusual | SEC |
| Jun 26, 2023 | Jun 26, 2023 | ONC | Officer | Form 144 notice | 1,108 | $202k | Notice | SEC | |
| Jun 20, 2023 | Jun 20, 2023 | ONC | Global Head of R&D | Form 4 sale | 1,325 | $255k | 100.0% | Unusual | SEC |
| Jun 20, 2023 | Jun 20, 2023 | ONC | Officer | Form 144 notice | 1,325 | $255k | Notice | SEC | |
| Jun 7, 2023 | Jun 9, 2023 | ONC | Global Head of R&D | Form 4 sale | 462 | $104k | 100.0% | Unusual | SEC |
| Jun 7, 2023 | Jun 7, 2023 | ONC | Officer | Form 144 notice | 462 | $104k | Notice | SEC | |
| Jun 27, 2022 | Jun 28, 2022 | ONC | Global Head of R&D | Form 4 sale | 458 | $81k | 100.0% | Unusual | SEC |
| Jun 21, 2022 | Jun 22, 2022 | ONC | Global Head of R&D | Form 4 sale | 1,168 | $170k | 100.0% | Unusual | SEC |
| Jun 6, 2022 | Jun 8, 2022 | ONC | Global Head of R&D | Form 4 sale | 660 | $94k | 100.0% | Unusual | SEC |
| Jun 28, 2021 | Jun 30, 2021 | ONC | Global Head of R&D | Form 4 sale | 455 | $165k | 100.0% | Unusual | SEC |
| Jun 18, 2021 | Jun 21, 2021 | ONC | Global Head of R&D | Form 4 sale | 802 | $266k | 100.0% | Unusual | SEC |
| Jun 7, 2021 | Jun 9, 2021 | ONC | Global Head of R&D | Form 4 sale | 656 | $232k | 100.0% | Unusual | SEC |